Monitoring to help prevent complications after cardiogenic shock
Part of Heart & circulation clinical trials.
This study tests a special monitoring approach (likely using an implanted device) to help prevent serious complications after you survive cardiogenic shock in the hospital. It may help the care team detect problems earlier so treatments can start sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your legal representative) can sign consent and complete study questionnaires.
- You are age 18 or older.
- You have heart failure symptoms that are worse with mild activity (NYHA Class III).
- This hospital stay includes cardiogenic shock and you survive to hospital discharge.
- You can use internet and phone to communicate with the research team.
- You will go home to an acute rehabilitation program (not hospice and not other care settings).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how well the CardioMEMS heart monitor works for people with heart failure. The device is already implanted and tracks pressure in your lung artery to help your doctor manage your condition and potentially prevent hospital visits.
This study checks how safe a small heart-pressure monitoring device is for people with advanced heart failure and severe kidney problems. It looks at whether doctors can continuously track heart filling/pressure to help manage symptoms and reduce risks.
This study tests a home monitoring device and follow-up care for people recently treated for heart failure in the emergency room. It aims to help manage your condition and avoid future hospital stays.
This study looks at how a small monitor inside the blood vessel to the lungs helps manage heart failure. It aims to improve care for people with advanced heart failure.
This study tests a remote monitoring device that sends information to your care team to help adjust your heart failure medications. It aims to improve your condition after a hospital stay for heart failure.
This study tests a small chest sensor that tracks your heart activity while you're in the hospital. It may help doctors better manage heart failure and prevent future crises.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.